Author

Marie Truyens 1

1 IBD Unit, Ghent University Hospital,Ghent,Belgium

EFFECTIVENESS OF THIRD-CLASS BIOLOGIC TREATMENT IN CROHN´S DISEASE: A MULTI-CENTER RETROSPECTIVE COHORT STUDY

Ahmad Albshesh, Joshua Taylor, Edoardo Vincenzo Savarino, Marie Truyens, Alessandro Armuzzi, Davide Giuseppe Ribaldone, Ariella Shitrit, Morine Fibelman, Pauliina Molander, Claire Liefferinckx, Stephane Nancy, Mohamed Korani, Klaudia Farkas, Manuel Barreiro de Acosta, Viktor Domislovic, Gerard Surís, Carl Eriksson, Catarin

EFFICACY OF USTEKINUMAB INTENSIFICATION AND RE-INDUCTION IN CROHN'S DISEASE PATIENTS WITH INSUFFICIENT OR LOSS OF RESPONSE

Marie Truyens

Efficacy of Ustekinumab intensification and re-induction in Crohn's disease patients with insufficient or loss of response

Marie Truyens, Marleen Goossens, Elien Glorieus, Jeroen Geldof, Pieter Hindryckx, Triana Lobaton Ortega

LARGE DIFFERENCES IN IBD CARE AND EDUCATION ACROSS EUROPE, FIRST RESULTS OF THE PAN-EUROPEAN VIPER SURVEY

Nicolas Benech, Brigida Barberio, Vera Lanska, Jan Král, Andreas Blesl, Catarina Frias Gomes, Aileen Eek, Tiago Capela, Eduard Brunet, Lauranne Derikx, Matthias Lessing, Anthea Pisani, Marcin Włodarczyk, Haluk Tarik Kani, Dmytro Oliinyk, Jonathan Segal, Vita Skuja, Anna Kagramanova, Phil Harvey, Hubert Zatorski, Philipp

RETROSPECTIVE STUDY OF THE EFFECTIVENESS AND SAFETY OF USTEKINUMAB IN REFRACTORY CROHN'S DISEASE

Marie Truyens

Retrospective study of the effectiveness and safety of Ustekinumab in refractory Crohn's Disease

Marie Truyens, Marleen Goossens, Elien Glorieus, Jeroen Geldof, Pieter Hindryckx, Triana Lobaton Ortega

SAFETY OF VEDOLIZUMAB AND USTEKINUMAB IN ELDERLY IBD PATIENTS: A REAL-LIFE MULTICENTRIC COHORT STUDY

Cara De Galan, Harald Peeters, Francisco Mesonero Gismero, Marie Truyens, Ainara Elorza, Paola Torres, Liv Vandermeulen, Aranzazu Jauregui Amezaga, Rocío Ferreiro-Iglesias, Yamile Zabana, Tom Holvoet, Laia Peries Reverter, Jeroen Geldof, Triana Lobaton, Martine De Vos

Item 1 - 7 / 7
1